Matches in Wikidata for { <http://www.wikidata.org/entity/Q74069427> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q74069427 description "artículu científicu espublizáu en payares de 1997" @default.
- Q74069427 description "im November 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74069427 description "scientific article published on 01 November 1997" @default.
- Q74069427 description "wetenschappelijk artikel" @default.
- Q74069427 description "наукова стаття, опублікована в листопаді 1997" @default.
- Q74069427 name "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 name "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 type Item @default.
- Q74069427 label "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 label "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 prefLabel "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 prefLabel "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 P1433 Q74069427-0DFB5089-2776-409A-88EB-23386D6DDB36 @default.
- Q74069427 P1476 Q74069427-612CDA78-33DB-4408-A5BE-69919E17AB88 @default.
- Q74069427 P2093 Q74069427-1D2CC095-CA48-4937-9415-28C366C71C19 @default.
- Q74069427 P2093 Q74069427-316D6EA0-45F9-4DEE-9905-D6E6C597458D @default.
- Q74069427 P2093 Q74069427-7A9D1AF9-B0D8-451D-A741-53E37F2439BA @default.
- Q74069427 P2093 Q74069427-84198A3E-AD1B-4B09-B5DA-8C9FA1044AFB @default.
- Q74069427 P2093 Q74069427-F28F64BE-DF3C-4CB5-AA10-F53C4E182B4B @default.
- Q74069427 P2093 Q74069427-F681B753-9150-47DF-8704-3C74C75EE6FB @default.
- Q74069427 P304 Q74069427-A0E177E9-6FA1-4EDC-BA20-8CA0294D2510 @default.
- Q74069427 P31 Q74069427-90953946-A021-403E-B4A0-9A88F39D60D7 @default.
- Q74069427 P356 Q74069427-096996DB-553B-42B1-A8BB-2B20B8AE4894 @default.
- Q74069427 P433 Q74069427-DF684048-C23C-4C31-AFEA-D45575652A6C @default.
- Q74069427 P478 Q74069427-5FC0BAB6-141B-4A72-991D-E96A523874EF @default.
- Q74069427 P577 Q74069427-5A1FA99B-07D2-44FE-A259-7D0D5A03CFD5 @default.
- Q74069427 P698 Q74069427-B0626B96-F9A4-4159-AFC0-F08C864D4A3B @default.
- Q74069427 P356 00001813-199711000-00004 @default.
- Q74069427 P698 9436636 @default.
- Q74069427 P1433 Q4774128 @default.
- Q74069427 P1476 "Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies" @default.
- Q74069427 P2093 "A Avilés" @default.
- Q74069427 P2093 "A Talavera" @default.
- Q74069427 P2093 "E L Garcia" @default.
- Q74069427 P2093 "J C Díaz Maqueo" @default.
- Q74069427 P2093 "J Huerta-Guzman" @default.
- Q74069427 P2093 "M J Nambo" @default.
- Q74069427 P304 "937-942" @default.
- Q74069427 P31 Q13442814 @default.
- Q74069427 P356 "10.1097/00001813-199711000-00004" @default.
- Q74069427 P433 "10" @default.
- Q74069427 P478 "8" @default.
- Q74069427 P577 "1997-11-01T00:00:00Z" @default.
- Q74069427 P698 "9436636" @default.